Regeneron Pharmaceuticals (REGN)
Free Cash Flow
$3.52B
TTM · Period ending: · USD
REGN Free Cash Flow
Latest reported$3.52Bperiod ending
Latest reported$3.52Bperiod ending
REGN TTM Free Cash Flow (-$19.30M → $3.52B)
TTM free cash flow
High-resolution chart · PNG
REGN free cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Free Cash Flow (USD) |
|---|---|
| -31,811,000 | |
| -26,087,000 | |
| -34,405,000 | |
| -23,270,000 | |
| -26,925,000 | |
| -28,458,000 | |
| -19,500,000 | |
| -32,000,000 | |
| -20,200,000 | |
| -17,500,000 | |
| -13,200,000 | |
| -4,400,000 | |
| -9,400,000 | |
| -8,700,000 | |
| -8,200,000 | |
| -11,400,000 | |
| -16,800,000 | |
| -21,400,000 | |
| -28,900,000 | |
| -28,800,000 | |
| -33,000,000 | |
| -26,900,000 | |
| -21,500,000 | |
| -31,800,000 | |
| -26,700,000 | |
| -19,600,000 | |
| -27,400,000 | |
| -33,600,000 | |
| -34,200,000 | |
| -47,300,000 | |
| -40,300,000 | |
| 20,700,000 | |
| -26,700,000 | |
| -23,100,000 | |
| -19,300,000 | |
| -65,400,000 | |
| -13,600,000 |